The #1 prescribed oral medicine for allergic itch in dogs*
Rapid relief
Apoquel Tablet starts relieving allergic dog itch within 4 hours.1 Both Apoquel Tablet and Apoquel Chewable effectively control allergic itch within 24 hours.2,3
Safe and effective
Apoquel can be used for long-term maintenance or short-term therapy in dogs 12 months of age and older.2,4
Leading the pack
Apoquel Tablets have been prescribed for over 14 million dogs5 and are #1 in pet owner and vet satisfaction for oral medications for allergic dermatitis in dogs.**6,7
Help stop your dog’s itching in its tracks
IMPORTANT SAFETY INFORMATION: Do not use APOQUEL or APOQUEL CHEWABLE in dogs less than 12 months of age or those with serious infections. APOQUEL and APOQUEL CHEWABLE may increase the chances of developing serious infections, and may cause existing parasitic skin infestations or pre-existing cancers to get worse. Consider the risks and benefits of treatment in dogs with a history of recurrence of these conditions. New neoplastic conditions (benign and malignant) were observed in clinical studies and post-approval. APOQUEL and APOQUEL CHEWABLE have not been tested in dogs receiving some medications including some commonly used to treat skin conditions such as corticosteroids and cyclosporines. Do not use in breeding, pregnant, or lactating dogs. Most common side effects are vomiting and diarrhea. APOQUEL and APOQUEL CHEWABLE have been used safely with many common medications including parasiticides, antibiotics and vaccines. See full Prescribing Information for Apoquel at apoquelPI.com and Apoquel Chewable at apoquelchewablePI.com.
1. Gadeyne C, Little P, King VL, Edwards N, Davis K, Stegemann MR. Efficacy of oclacitinib (Apoquel®) compared with prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client-owned dogs in Australia. Vet Dermatol. 2014;25(6):512-518,e86. doi:10.1111/vde.12166
2. Cosgrove SB, Wren JA, Cleaver DM, et al. Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis. Vet Dermatol. 2013;24(5):479- e114. doi: 10.1111/vde.12047
3. Data on file: Study Report A161C-US-21-C02, Zoetis Inc.
4. Cosgrove SB, Cleaver DM, King VL, et al. Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life. Vet Dermatol. 2015;26(3):171-179, e35. doi: 10.1111/vde.12194
5. ZMR: Kynetec PetTrak – Pets Since Launch September 2023, Zoetis Services LLC.
6. Data on file, APOQUEL/CYTOPOINT Vet Tracker Wave 17, 2022, Zoetis Inc.
7. Data on file, APOQUEL/CYTOPOINT Pet Owner Tracker Wave 11, 2022, Zoetis Inc.